Cyrus Biotechnology Spins out Levitate Bio, a Protein AI, Bioinformatics, and Rosetta Service Provider, to Bring Automated, Customized AI Solutions to Biopharma Drug Discovery
Cyrus Biotechnology, Inc., a Seattle-based software-enabled biotechnology firm, is spinning out a software and services group, Levitate Bio, to bring the Cyrus platform to the larger biopharma industry.
- Cyrus Biotechnology, Inc., a Seattle-based software-enabled biotechnology firm, is spinning out a software and services group, Levitate Bio, to bring the Cyrus platform to the larger biopharma industry.
- Cyrus will continue to benefit from the platform while Levitate builds a broader business across biopharma.
- The Rosetta Commons Foundation was created by the Rosetta Commons, a multi-institution collaboration that developed the Rosetta biomolecular modeling suite.
- Leveraging this lineage, both Cyrus and Levitate have refined software developed by Rosetta Commons labs, enhancing it for automated use.